Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2–dependent fibrinolysis
- 19 October 2009
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 119 (11), 3384-3394
- https://doi.org/10.1172/jci39591
Abstract
When plasma levels of homocysteine (HC), a thiol amino acid formed upon methionine demethylation, exceed 12 μM, individuals are at increased risk of developing large vessel atherothrombosis and small vessel dysfunction. The annexin A2 complex (termed “A2”) is the cell surface coreceptor for plasminogen and TPA and accelerates the catalytic activation of plasmin, the major fibrinolytic agent in mammals. We previously showed that HC prevents A2-mediated, TPA-dependent activation of plasminogen in vitro by disulfide derivatization of the “tail” domain of A2. We also demonstrated that fibrinolysis and angiogenesis are severely impaired in A2-deficient mice. We now report here that, although hyperhomocysteinemic mice had a normal coagulation profile and normal platelet function, fibrin accumulated in their tissues due to reduced perivascular fibrinolytic activity and angiogenesis was impaired. A2 isolated from hyperhomocysteinemic mice failed to fully support TPA-dependent plasmin activation. However, infusion of hyperhomocysteinemic mice with fresh recombinant A2, which localized to neoangiogenic endothelial cells, resulted in normalization of angiogenesis and disappearance of peri- and intravascular fibrin. We therefore conclude that hyperhomocysteinemia impairs postnatal angiogenesis by derivatizing A2, preventing perivascular fibrinolysis, and inhibiting directed endothelial cell migration. These findings provide a mechanistic explanation for microvascular dysfunction and macrovascular occlusion in individuals with hyperhomocysteinemia.Keywords
This publication has 69 references indexed in Scilit:
- Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potentialJournal of Thrombosis and Haemostasis, 2008
- Dietary methionine effects on plasma homocysteine and HDL metabolism in miceThe Journal of Nutritional Biochemistry, 2008
- Genes, endothelial function and cerebral small vessel disease in manExperimental Physiology, 2007
- Acute Hyperhomocysteinemia Induces Microvascular and Macrovascular Endothelial DysfunctionArchives of Medical Research, 2007
- Asymmetric Dimethylarginine in Cerebral Small Vessel DiseaseStroke, 2007
- Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularizationJCI Insight, 2006
- Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: An overviewJournal of Inherited Metabolic Disease, 2006
- Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trialsAmerican Heart Journal, 2004
- HOMOCYSTEINE METABOLISMAnnual Review of Nutrition, 1999
- Interaction of the Fibrinolytic Receptor, Annexin II, with the Endothelial Cell SurfaceJournal of Biological Chemistry, 1996